Clinical Studies

Bronchiectasis Clinical Trial

Bronchiectasis is a chronic inflammatory disease where the walls of the bronchi are thickened from inflammation & infection. Patients suffer from daily cough and sputum production and experience frequent exacerbations (worsening).

Symptoms include:

- Coughing of yellow or green sputum daily
- Shortness of Breath
- Fatigue
- Chest pain

You may qualify for this no-cost clinical trial if you:

- Are 18 - 85 years of age
- Diagnosis of Bronchiectasis affecting one or more lobes
- At least 2 pulmonary exacerbations in the past 12 months

Qualified volunteers may receive at no cost:

- Study medication
- Study-related care
- Reimbursement for your travel

Gonorrhea Clinical Trial

Gonorrhea is an infection caused by a bacteria spread by sexual contact and can cause serious health problems if left untreated for too long. It is important to get tested and/or treated if you think you have gonorrhea or have a partner with gonorrhea.

Symptoms include:

- Green, yellow, or white discharge from the penis or vagina
- A burning feeling in the throat or when urinating
- Pain in the pelvis or testicles

You may qualify for this no-cost clinical trial if you:

- Are at least 12 years of age
- Have a suspected gonorrhea infection

Qualified volunteers may receive at no cost:

- Study medication for gonorrhea
- Study-related care
- Reimbursement for your travel

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial

COPD is a chronic inflammatory lung disease which causes obstructed airflow from the lungs. COPD is most often caused from a smoking history and may increase your risk of heart disease and lung cancer.

Symptoms include:

- Breathing difficulty/Shortness of breath
- Coughing/Wheezing Chest tightness
- Sputum (mucus) production

You may qualify for this no-cost clinical trial if you:

- Are 40 - 85 years of age
- Have moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
- History of 2 moderate or 1 severe COPD exacerbations in the previous 12 months
- Use of triple (ICS/LABA/LAMA) therapy for COPD

Qualified volunteers may receive at no cost:

- Study medication
- Study-related care
- Reimbursement for your travel

Coronavirus (COVID-19) Clinical Trial

COVID-19 is a disease caused by the novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) first identified in 2019.

Symptoms include:

- Fever or chills
- Loss of taste and/or smell
- Cough
- Muscle or body aches
- Shortness of breath or difficulty breathing
- Headache
- Fatigue
- Sore throat
- Runny nose or congestion
- Nausea or vomiting
- Diarrhea

You may qualify for this no-cost clinical trial if you:

- Are at least 18 years of age
- Recently tested positive for COVID-19

Have at least one of the following risk factors:
- Age 65 years or older
- Diabetes Mellitus
- Hypertension
- Chronic heart, lung, or liver disease
- 35 lbs or more overweight

Qualified volunteers may receive at no cost:

- Study medication
- Study-related care
- Reimbursement for participation

Idiopathic Pulmonary Fibrosis (IPF) Clinical Trial

IPF is a a chronic, progressive, irreversible, and usually lethal lung disease of unknown cause that occurs mostly in elderly adults.

Symptoms include:

- Worsening cough & shortness of breath
- Fatigue
- Unexplained weight loss
- Muscle & joint pain

You may qualify for this no-cost clinical trial if you:

- Are 40-85 years of age
- Have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF) within the last 3 years

Qualified volunteers may receive at no cost:

- Study medication
- Study-related care
- Reimbursement for your travel

Human Immunodeficiency Virus (HIV) Clinical Trial

This clinical trial is for Heavily treatment-experienced (HTE) individuals. HTE individuals have exhausted all or nearly all antiretroviral options because of extensive multi drug resistance but also due to drug intolerance, lack of access to medication, or unwillingness to take medications due to route of administration (injections, multiple oral medications, etc.)

You may qualify for this no-cost clinical trial if you:

- Are 12 years of age or older
- HIV +
- Currently on failing
- Antiretroviral
- Therapy (ART)
- From “RNA ≥ 500 copies/mL” to “Viral load ≥ 500 copies/mL)
- Weigh ≥ 35 kg (77.2 lbs)

Qualified volunteers may receive at no cost:

- Study medication
- Study-related care
- Reimbursement for your travel

Erosive Esophagitis (EE) Clinical Trial

Erosive Esophagitis is a disorder caused by reflux of gastric acid into the esophagus which, over time, can cause tissue damage to the lining of the esophagus.

Symptoms include:

- Chest pain
- Nausea
- Heartburn
- Difficult and/or painful swallowing

You may qualify for this no-cost clinical trial if you:

- Are ≥ 18 years of age
- Have Erosive Esophagitis (EE)
 

Qualified volunteers may receive at no cost:

- Study medication
- Study-related care
- Reimbursement for your travel

Helicobacter Pylori (H. Pylori) Clinical Trial

Helicobacter pylori is a gram-negative, microaerophilic (requires oxygen) bacterium found on human gastric mucosa (stomach) that if left untreated can lead to gastric cancer.

Symptoms include:

- Loss of appetite
- Nausea
- Bloating
- Frequent burping
- Ache or burning pain in the abdomen
- Unintentional weight loss

You May qualify for this no-cost clinical trial if you:

- Are ≥ 18 years of age
- Have confirmed Helicobacter Pylori (H. Pylori)

Qualified volunteers may receive at no cost:

- Study medication
- Study-related care
- Reimbursement for your travel

Clostridium difficile (C. diff) Clinical Trial

Clostridium difficile is a bacteria that causes severe diarrhea and inflammation of the colon that can occur during or after taking antibiotics. This clinical trial is for the prevention of C. diff infection (CDI) recurrence. The study is to see how well ART24 (novel oral study medication) is tolerated and how well ART24 can help prevent future episodes of C. difficile infection compared to placebo.

Symptoms include:

-  Watery Diarrhea 3 or more times a times a day for 2 or more days
Nausea, Dehydration, Loss of appetite
- Abdominal cramping and pain

You May qualify for this no-cost clinical trial if you:

- Are 18-75 years of age
- Are currently taking or have recently finished (within the last 6 days) taking antibiotics for a C. difficile infection
- Do not have Inflammatory Bowel Disease (IBD)
- Other criteria may apply

Qualified volunteers may receive at no cost:

-ART24 or placebo
- Study-related medication and exams at no cost
- Compensation for reasonable travel and meal expenses

Colorectal Cancer (CRC) & Advanced Neoplasia (AN) Clinical Study

If you 45-84 years of age and are scheduled to undergo a screening colonoscopy and considered as ‘average risk’ for colorectal cancer, you may qualify for this blood sample collection study.

- Single visit for blood sample collection prior to your scheduled colonoscopy
- Compensation for qualified participants
- The purpose of this clinical study is to collect blood samples to better understand the biomarkers of patients with colorectal cancer and help develop a blood-based screening test. Biomarkers are biologic features found in the blood and may be related to cancer risk.

Health insurance and doctor referrals are not required to participate in the clinical trials & clinical studies.